Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
IM or IV delivery puts it directly into the bloodstream, oral precursors like NMN have to be converted first, which is variable
To meet the demand, health providers like Hims & Hers had jumped on the opportunity to provide compounded versions of the weight-loss medications, which haven't been on the market long enough to have generic equivalents
How soon are results visible
The incidence varies considerably between different medications and doses: Semaglutide (Ozempic): Vomiting occurs in approximately 5-10% of patients at diabetes doses Semaglutide (Wegovy): At the higher weight management dose (2.4mg), vomiting affects up to 16% of patients Liraglutide (Victoza): Vomiting affects approximately 5% of patients Liraglutide (Saxenda): At weight management doses, vomiting occurs in about 7-10% of patients Dulaglutide (Trulicity): Vomiting affects approximately 7-9% of patients Tirzepatide (Mounjaro): Vomiting occurs in approximately 5-10% of patients, varying by dose These side effects are most pronounced during the initial treatment phase, particularly in the first 48 weeks, and often diminish as the body adapts to the medication
US$ 25.16
US$ 20.11
US$ 20.20
US$ 28.03
US$ 27.13
US$ 23.75
US$ 27.69
US$ 25.67
US$ 29.97
US$ 25.73
US$ 23.51
US$ 24.37
